Back to Trades
Innovative Cellular Therapeutics Holdings Ltd
InsiderCIK 0002095697
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Innovative Cellular Therapeutics Holdings Ltd has filed 7 SEC reports (2026), all concentrated in Lyell Immunopharma, Inc. (LYEL), totaling $274 in disclosed volume. Weighing $0 bought versus $274 sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 27 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Other | $0 |
| Jul 27 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Other | $0 |
| Jul 20 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Sell | $137 |
| Jul 17 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Sell | $137 |
| Jul 1 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Other | $0 |
| Jun 18 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Other | $0 |
| Jun 18 | LYEL Lyell Immunopharma, Inc. | Innovative Cellular Therapeutics Holdings Ltd | Insider | Other | $0 |
7 filings